O
OrbiMed’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-387,000
| Closed | -$44.2M | – | 123 |
|
|
2024
Q3 | $44.2M | Sell |
387,000
-408,900
| -51% | -$46.7M | 0.8% | 39 |
|
|
2024
Q2 | $60.1M | Sell |
795,900
-270,231
| -25% | -$20.4M | 1.19% | 25 |
|
|
2024
Q1 | $72.8M | Sell |
1,066,131
-86,960
| -8% | -$5.94M | 1.33% | 26 |
|
|
2023
Q4 | $72.4M | Buy |
1,153,091
+145,943
| +14% | +$9.17M | 1.45% | 23 |
|
|
2023
Q3 | $51.3M | Hold |
1,007,148
| – | – | 1.09% | 31 |
|
|
2023
Q2 | $50.3M | Buy |
1,007,148
+277,709
| +38% | +$13.9M | 0.91% | 40 |
|
|
2023
Q1 | $27.3M | Sell |
729,439
-553,687
| -43% | -$20.8M | 0.54% | 57 |
|
|
2022
Q4 | $61.5M | Buy |
1,283,126
+565,226
| +79% | +$27.1M | 1.18% | 29 |
|
|
2022
Q3 | $17.2K | Sell |
717,900
-795,759
| -53% | -$19.1K | 0.32% | 69 |
|
|
2022
Q2 | $32.9K | Hold |
1,513,659
| – | – | 0.6% | 53 |
|
|
2022
Q1 | $36.6M | Buy |
1,513,659
+416,959
| +38% | +$10.1M | 0.59% | 49 |
|
|
2021
Q4 | $26.1M | Buy |
1,096,700
+62,035
| +6% | +$1.48M | 0.34% | 70 |
|
|
2021
Q3 | $26.2M | Buy |
1,034,665
+89,265
| +9% | +$2.26M | 0.29% | 84 |
|
|
2021
Q2 | $21.3M | Buy |
945,400
+296,626
| +46% | +$6.68M | 0.22% | 97 |
|
|
2021
Q1 | $12.8M | Buy |
648,774
+18,514
| +3% | +$366K | 0.12% | 113 |
|
|
2020
Q4 | $16.7M | Sell |
630,260
-10,500
| -2% | -$279K | 0.15% | 107 |
|
|
2020
Q3 | $31.6M | Sell |
640,760
-209,240
| -25% | -$10.3M | 0.4% | 68 |
|
|
2020
Q2 | $26.9M | Buy |
+850,000
| New | +$26.9M | 0.38% | 66 |
|